University of Padova
Also known as: Azienda L'ULSS 15 Alta Padovana | Azienda Ospedaliera di Padova | Azienda Ospedaliera Padova | Azienda Ospedaliera Universitaria di Padova | Az Osp Padova, Osp. Civile Padova | Biostatistic and Epidemiology Unit, Department of Enviromental Medicine and Public Health, University of Padova, Italy | Clinica Oculistica, Padova | Clinica Oculistica, Padova (Italy) | Clinica Pediatrica, Padova | Department of General Psychology, University of Padova | Department of Medicine, University of Padova. | Dept. Clinical and Experimental Medicine, University of Padova, Medical School, Padova (Italy) | Dept. of Clinical and Experimenatl Medicine, University of Padova, Italy | Dept. of Medicine, University of Padova, Medical School, Padova (Italy) | Faculty of Medicine, University of Padova (Padova, Italy) | Gian Paolo Fadini | Oncologia Ospedale di Padova | Padova University | Padova University, Department of Surgical and Gastroenterological Sciences, 1st Surgical Clinic | Padova University Hospital, Italy | UNIVERSITA DEGLI STUDI DI PADOVA (UNIPD) | Universita di Padova | University Hospital Padova | University of Padova | University of Padova, Department of Surgical and Gastroenterological Sciences, 1st Surgical Clinic | University of Padova - Italy | University of Padova, Italy | University of Padova, Medical School | University of Padova, Padova, Italy | University of Padova, School of Dental Medicine | U.O.C. Anestesia e Rianimazione. A.O. U.L.S.S.15 Alta Padovana, Presidio Camposampiero. Camposampiero - Padova | U.O.C Chirurgia Epatobiliare e dei Trapianti Epatici, AOPD
Highest phase reached
Phase 4
First clinical trial
Jul 1, 1992Last known activity
Sep 1, 2024
Timeline
1220s
- Jan 1, 1222
University of Padova— Founded
Drugs by trial phase (122 distinct, 94 trials)
Phase 4 (23 own, 0 via acquisition)
Phase 3 (52 own, 0 via acquisition)
Phase 2 (24 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Studied for
- Acidosis
- Amyotrophic Lateral Sclerosis
- Antiphospholipid Syndrome
- Ascites
- Asthma
- Atrial Fibrillation
- Bacterial Infections
- Blood Platelet Disorders
- Breast Neoplasms
- Burning Mouth Syndrome
- Burns
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Renal Cell
- Cardiovascular Diseases
- Central Nervous System Neoplasms
- Cholangitis
- Communicable Diseases
- Conjunctivitis, Allergic
- Delayed Emergence from Anesthesia
- Dermatitis
- Dermatitis, Atopic
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Retinopathy
- Empyema
- Empyema, Pleural
- Esophageal and Gastric Varices
- Esophageal Neoplasms
- Fibrosis
- Fungemia
- Glioblastoma
- Glucose Intolerance
- Hepatic Insufficiency
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Hepatitis C, Chronic
- Hepatitis, Chronic
- Hepatoblastoma
- Hepatorenal Syndrome
- Histiocytoma
- Histiocytoma, Benign Fibrous
- Histiocytoma, Malignant Fibrous
- HIV Infections
- Hypercholesterolemia
- Infections
- Infertility
- Infertility, Male
- Inflammation
- Insulin Resistance
- Ischemia
- Keratoconjunctivitis
- Kidney Failure, Chronic
- Liver Cirrhosis
- Liver Diseases
- Liver Failure
- Liver Failure, Acute
- Liver Neoplasms
- Macular Degeneration
- Mental Disorders
- Motor Neuron Disease
- Mucopolysaccharidoses
- Mucopolysaccharidosis II
- Muscle Spasticity
- Mycoses
- Neoplasm Metastasis
- Nervous System Neoplasms
- Obesity, Morbid
- Osteoarthritis
- Osteoporosis
- Peritonitis
- Pneumonia
- Postoperative Pain
- Prediabetic State
- Psoriasis
- Renal Insufficiency
- Renal Insufficiency, Chronic
- Retinal Diseases
- Rhabdomyosarcoma
- Sarcoma
- Sclerosis
- Sepsis
- Status Epilepticus
- Substance Withdrawal Syndrome
- Syndrome
- Synovitis
- Thrombocytopenia
- Thromboembolism
- Thrombosis
- Toxemia
- Triple Negative Breast Neoplasms
- Urinary Tract Infections
- Venous Thromboembolism
- Venous Thrombosis
- Wet Macular Degeneration
- Wounds and Injuries
Recent trials (50)
- NCT07148726Lead sponsorN/ASep 1, 2024
- NCT06576700Lead sponsorN/AJun 15, 2024
- NCT06982703Lead sponsorN/AJun 15, 2024
- NCT06576700OfficialN/AJun 15, 2024
- NCT05702970Lead sponsorPhase 4Jan 15, 2024
- NCT05702970Study directorPhase 4Jan 15, 2024
- NCT05702970Overall official - principal investigatorPhase 4Jan 15, 2024
- NCT06169046Lead sponsorPhase 2Jan 8, 2024
- NCT06169046Sponsor investigatorPhase 2Jan 8, 2024
- NCT06073327Overall official - principal investigatorN/AMay 3, 2023
- NCT06073327Lead sponsorN/AMay 3, 2023
- NCT05399966Lead sponsorN/AJan 2, 2023
- NCT05399966Sponsor investigatorN/AJan 2, 2023
- NCT05542147Sponsor investigatorN/AJul 3, 2022
- NCT05542147Lead sponsorN/AJul 3, 2022
Details
- Founded
- Padova, IT Jan 1, 1222
- Last known activity
- Sep 1, 2024